Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.

about

Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.

Item

http://www.wikidata.org/entity/Q55097343

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@en

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@nl

type

Item

label

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@en

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@nl

prefLabel

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@en

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@nl

P1476

Matrix metalloproteinase-14 is ...... ferative diabetic retinopathy.

@en

P2093

Ahmed M Abu El-Asrar

http://www.w3.org/2001/XMLSchema#string

Ajmal Ahmad

http://www.w3.org/2001/XMLSchema#string

Eef Allegaert

http://www.w3.org/2001/XMLSchema#string

Gert De Hertogh

http://www.w3.org/2001/XMLSchema#string

Ghislain Opdenakker

http://www.w3.org/2001/XMLSchema#string

Ghulam Mohammad

http://www.w3.org/2001/XMLSchema#string

Kaiser Alam

http://www.w3.org/2001/XMLSchema#string

Mohammad Mairaj Siddiquei

http://www.w3.org/2001/XMLSchema#string

Priscilla W Gikandi

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of fibrosis

Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier

Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Angiogenesis in health and disease

Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.

Treatment of proliferative diabetic retinopathy with anti-VEGF agents.

Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction

S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis.

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

P304

394-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29853773

http://www.w3.org/2001/XMLSchema#string

P932

5957543

http://www.w3.org/2001/XMLSchema#string